Ani Pharmaceuticals (ANIP) Current Deferred Revenue (2012 - 2022)
Ani Pharmaceuticals (ANIP) reported Current Deferred Revenue of $116000.0 for Q1 2022, up 16.0% on a YoY basis from $100000.0 in Q1 2021, and up 16.0% sequentially from $100000.0 in Q4 2021.
Ani Pharmaceuticals (ANIP) Current Deferred Revenue (2012 - 2022) Analysis & Trends
Ani Pharmaceuticals (ANIP) has 8 years of Current Deferred Revenue data on file, last reported at $116000.0 in Q1 2022.
- For the quarter ending Q1 2022, Current Deferred Revenue rose 16.0% year-over-year to $116000.0; the trailing twelve-month figure through Mar 2022 stood at $116000.0 (up 16.0% YoY), and the FY2021 full-year result was $100000.0, up 25.0% from the prior year.
- Current Deferred Revenue improved to $116000.0 in Q1 2022, from $100000.0 in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $735000.0 in Q3 2018 to a low of $62000.0 in Q3 2021.
- A 5-year average of $315000.0 and a median of $125000.0 in 2020 frame the typical range for Current Deferred Revenue.
- Across the five-year window, Current Deferred Revenue tumbled 84.0% in 2020 and climbed 25.0% in 2021, its largest moves.
- Tracing ANIP's Current Deferred Revenue over 5 years: stood at $711000.0 in 2018, then slipped by 29.68% to $500000.0 in 2019, then plunged by 84.0% to $80000.0 in 2020, then rose by 25.0% to $100000.0 in 2021, then grew by 16.0% to $116000.0 in 2022.
- Business Quant data shows ANIP's Current Deferred Revenue at $116000.0 in Q1 2022, $100000.0 in Q4 2021, and $62000.0 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Ani Pharmaceuticals | 1.64 Bn | 1.33 Bn | 143.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 116,000.00 |
| Dec 31, 2021 | 100,000.00 |
| Sep 30, 2021 | 62,000.00 |
| Jun 30, 2021 | 100,000.00 |
| Mar 31, 2021 | 100,000.00 |
| Dec 31, 2020 | 80,000.00 |
| Sep 30, 2020 | 100,000.00 |
| Jun 30, 2020 | 125,000.00 |
| Mar 31, 2020 | 318,000.00 |
| Dec 31, 2019 | 500,000.00 |
| Sep 30, 2019 | 496,000.00 |
| Jun 30, 2019 | 558,000.00 |
| Mar 31, 2019 | 624,000.00 |
| Dec 31, 2018 | 711,000.00 |
| Sep 30, 2018 | 735,000.00 |
| Sep 30, 2014 | 20,000.00 |
| Jun 30, 2014 | 13,000.00 |
| Mar 31, 2014 | 38,000.00 |
| Dec 31, 2013 | 47,000.00 |
| Sep 30, 2013 | 46,712.00 |